PEPTIDES (175 Offers)
Product Information
Dragon PharmaCompound Details
Active Substance Vesilute (Glu-Asp) Lyophilized bioregulatory dipeptide (Khavinson)
20 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Limited human data
Detection Up to several weeks
Primary Mechanism Proposed Urogenital Gene-Expression Modulation
Cellular / Regenerative Impact Low
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance BPC-157 Lyophilized synthetic pentadecapeptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Multidose Vial
Estimated Half-Life Limited human data
Detection Up to several weeks
Primary Mechanism Angiogenesis / VEGF Pathway Upregulation
Tissue Repair / Healing High (preclinical)
Kalpa Pharmaceuticals LTD, India
For Mixing Powder
Composition: Sterile Water
Dosage: 0.9%/vial
Unit: 2 mL Multidose Vial
Manufactured by Kalpa Pharmaceuticals
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance GHK-Cu (Copper Peptide) Lyophilized copper-binding tripeptide
50 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Copper-Dependent Collagen & Tissue Remodeling
Tissue Repair / Healing High (preclinical)
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Somatropin (191aa) Lyophilized recombinant human growth hormone
20 IU per vial
Form Lyophilized Powder
Packaging 1 Kit (10 × 2 mL Vials)
Estimated Half-Life Approximately 2–3 Hours
Detection Up to 1–2 Days
Primary Mechanism GH Receptor Agonism / IGF-1 Induction
GH / IGF-1 Impact High
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance MOTS-c Lyophilized mitochondrial-derived peptide (12S rRNA-c)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism AMPK Activation / Mitochondrial Retrograde Signalling
Metabolic / Endurance Impact High
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Thymosin Beta-4 Lyophilized synthetic peptide (full-length, 43 aa)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism Actin Cytoskeleton Regulation / Cell Migration
Tissue Repair / Healing Moderate
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Peptide Hubs
Product Information
Peptide HubsCompound Details
Active Substance Epitalon (Epithalon) Lyophilized synthetic tetrapeptide (Ala-Glu-Asp-Gly)
25 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Limited human data · short-acting
Detection Limited data · Up to several weeks
Primary Mechanism Telomerase Activation / Pineal Modulation
Cellular / Regenerative Impact Moderate (limited human data)
Product Information
Peptide HubsCompound Details
Active Substance GHRP-6 Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Multidose Vial
Estimated Half-Life Approximately 15–60 Minutes
Detection Limited data · Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact High
Peptide Hubs
Product Information
Peptide HubsCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Limited data · Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Axiolabs
Product Information
AxiolabsCompound Details
Active Substance Somatropin (191aa) Lyophilized recombinant human growth hormone
20 IU per vial
Form Lyophilized Powder
Packaging 1 Kit (10 × 2 mL Vials)
Estimated Half-Life Approximately 2–3 Hours
Detection Up to 1–2 Days
Primary Mechanism GH Receptor Agonism / IGF-1 Induction
GH / IGF-1 Impact High
Axiolabs
For Subqutaneous Injection
Composition: Somatropin (r-hGH)
Form: Powder
Dosage: 10 IU/vial
Unit: 1 Kit [10 Vials]
Manufactured by Axiolabs
Axiolabs
Product Information
AxiolabsCompound Details
Active Substance BPC-157 Lyophilized synthetic pentadecapeptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Multidose Vial
Estimated Half-Life Limited human data
Detection Up to several weeks
Primary Mechanism Angiogenesis / VEGF Pathway Upregulation
Tissue Repair / Healing High (preclinical)
